Dr. Lee S. Cohen, Director of the Ammon-Pinizzotto Center for Women's Mental Health at Massachusetts General Hospital, recently shared his insights on practicing perinatal psychiatry during the ongoing COVID-19 pandemic with Ob.Gyn News on November [...]
“Together in Mind” is a group intervention for mothers diagnosed with moderate to severe mental illness and their infants.
Some, but not all, studies suggest that PMDD is a risk factor for postpartum depression.
This study will evaluate the effectiveness of two digital (app- or web-based) interventions for the treatment of OCD.
Further systematic research on outcomes after postpartum screening is needed to ensure that screening translates into improved clinical outcomes.
Pandemic-related grief, but not anxiety, was associated with lower quality bonding.
The FDA will review zuranolone for the treatment of depression in the first half of 2022.
This review discusses the novel neurosteroid antidepressant brexanolone for the treatment of postpartum depression.
Psychological interventions provided by nurses and midwives can significantly reduce the severity of perinatal depressive symptoms.
In a webinar put together by 2020 Mom, presenters provide an overview of maternal suicide, review risk factors for suicide in this population, and discuss efforts to generate accurate data on maternal suicide.
